|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| C07K 16/2818 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K2317/14 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/565 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3883966 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19829506.5 |
| Date of filing the European patent application | 2019-12-17 | |
| (97) | Date of publication of the European application | 2021-09-29 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2019/085776 |
| Date | 2019-12-17 |
| (87) | Number | WO 2020/127366 |
| Date | 2020-06-25 |
| (30) | Number | Date | Country code |
| 18306801 | 2018-12-21 | EP |
| (72) |
POIRIER, Nicolas , FR
MARY, Caroline , FR
THEPENIER, Virginie , FR
MORELLO, Aurore , FR
PENGAM, Sabrina , FR
|
| (73) |
OSE Immunotherapeutics ,
22, boulevard Benoni Goullin, 44200 Nantes,
FR
|
| (54) | HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY |
| HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY |